Abstract
Dr Graham Clarke is the senior director and head of the respiratory and inflammation unit, Early Clinical Development, at Quintiles, London. He leads the development and execution of inhaler generics and inhaler characterization studies, biomarker identification efforts and the development of challenge models of inflammation across several therapeutic areas. After previous appointments in molecular and forensic analytical biology and subsequently training as a clinical physiologist at the Royal Brompton Hospital, London, UK, Dr Clarke has served in a variety of respiratory clinical research environments. He is an honorary research fellow in cardiothoracic pharmacology at Imperial College London’s National Heart and Lung Institute. Dr Clarke completed a PhD in respiratory pharmacology and physiology with a focus on airway and vascular hyper-responsiveness in asthma at King’s College, London, UK.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.